Rare thoughts & outcomes – navigating pathways to better outcomes in rare
September 14, 2021 |
Mobilizing pathway change – what the past 25 years have shown me
Welcome to OPEN Health’s second Rare Thoughts & Outcomes theme for 2021 – Navigating pathways to better outcomes. This is a topic close to my heart, and so it’s great to be focusing on how positive pathway change can lead to better outcomes across the Rare community.
Given rarity’s, lack of disease knowledge, and limited treatment options, current pathways are not fit for purpose, meaning people living with Rare often don’t experience optimal outcomes. In addition to poor outcomes, ineffective diagnostic, treatment, and management pathways can cause healthcare inefficiencies and lack of sustained uptake of innovation.
This theme will look at the key pillars to enable pathway change across all stakeholder groups, with a particular focus on how our clients can play a role in facilitating positive change. There will be a number of discussions and articles from across our centers of excellence on this wide-ranging topic, and we look forward to you joining us on this journey!
In the meantime, here are my top-line thoughts on its importance and how we can achieve better results:
It’s scary to say but this is my 25th year of working in the health care industry! Throughout that time, I have observed the very good, the bad, and the ugly when it comes to biopharmaceutical companies (Pharma) playing their part in positive pathway change. I have also been involved in many pathway change projects, including becoming a Black Belt in Lean Six Sigma pathway improvement. The statistics element of that was tough, but the real learnings came from the following communications-led imperatives:
- Demonstrating the value of change
- Bringing ALL stakeholders on the journey
- Co-creating solutions
- Proving the impact of change
There remains such an opportunity to work closer, better, and faster to deliver a real difference for those living with Rare, while bringing benefits to health care systems, society, and Pharma. It’s a cliché but WIN-WIN-WIN opportunities are there for the taking; if we can find ways of further connecting the combined force of the Rare community to bear on the challenges faced by patients and their families, we can ensure patients receive the optimal care and the best experience.
Mobilizing effective and sustained change in healthcare is never simple, but holding firm some core principles will help, such as:
- Patient first
Maintaining a clear focus on patient outcomes as the primary driver for partnerships will help sustain trust between stakeholder groups. In addition, transparency on how every part of the partnership benefits from achieving the primary objective will also strengthen long-term commitment.
- Communicate, Communicate, and err Communicate
You basically can’t do too much of this to ensure that stakeholders are made aware of the need for change and understand how it can happen and what value it will bring. Transparency of intent is essential for Pharma to build trust in their objectives and demonstrate that the company is looking ‘beyond therapeutics’.
- Co-create tools that enable change
A multitude of options here, from burden of illness data to preceptorship programs and patient support activities. It’s critical that there is cross- functional collaboration within Pharma to ensure that these tools not only complement each other but really meet the users’ needs to drive positive change.
- Measure and celebrate success
Tracking the benefits of pathway improvement will help sustain long-term the change. This feels very prescient for Pharma at this time given the volume of potential one-time treatment emerging. Communicating positivity and best practice for how it was achieved is critical to mobile change into the future
We are looking forward to sharing further thinking soon and hope everyone finds some value in our efforts! Stay tuned……
For any questions about our Rare Thoughts & Outcomes theme or to learn more about our commitment to Rare. Please contact:
Gavin Jones, Global Advisor, Rare Diseases
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
NORD Rare Diseases Breakthrough Summit
Gavin Jones, Director of Rare Disease, provides his thoughts on last week’s NORD Breakthrough Summit and a collective need to reduce inequalities in rare disease
The Patient as Priority: How can effective internal training contribute to improving patient outcomes?
Hear from OPEN Health's Briony Frost
A day in the life of Becca McConnell a Senior Account Executive
We asked Becca McConnell to give us an insight into her role as Senior Account Executive at OPEN Health.
Responding to dynamic shifts in value communications
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies.
OPEN Health’s Digital team have won a Bronze Award at the PM Society Digital Awards 2020
We are delighted to have won another Bronze Award at the PM Society Digital Awards 2020in the Healthcare Charities & Patient Associations Category for Alexander Devine Children's Hospice Service. READ MORE ABOUT OUR...
OPEN Health’s Learning & Development team have won a Bronze Award at the PM Society Digital Awards 2020
We are delighted to have won a Bronze Award at the PM Society Digital Awards 2020 for Excellence in Innovation: Immunology Training Summit.READ MORE ABOUT OUR WINNING PROJECT WITH WITH JANSSEN BELOW:The Immunology...
OPEN VIE is awarded a Bronze Award at the PM Society Digital Awards 2020
We are delighted to have won a Bronze Award at the PM Society Digital Awards 2020 for Effectiveness: Market Access.READ MORE ABOUT OUR WINNING PROJECT “VAGUS NERVE STIMULATION - ADDRESSING INEQUALITY...
Meet OPEN Health and Pharmerit Experts at the World Pharma Pricing Market Access and Evidence Congress 2020
Join OPEN Health and Pharmerit – an OPEN Health Company at the World Pharma Pricing Market Access and Evidence Congress from 23 – 25 September 2020, as we present:ROUNDTABLE: Wednesday, September 23,...
Reflections of a Fireside Chat from the World Orphan Drug Congress 2020
Hear from Trish Shepherd COO, Patient & Brand Communications, OPEN Health
OPEN Health has been awarded a Bronze Medal by EcoVadis
We are delighted to announce that OPEN Health has been awarded a Bronze Medal by EcoVadis for its very first Corporate Social Responsibility assessment in recognition of its commitment to Corporate Social...